Market Closed -
Oslo Bors
10:45:00 2024-04-25 am EDT
5-day change
1st Jan Change
190
NOK
0.00%
-0.63%
+10.85%
Borregaard : Quarterly and accounting figures 3rd quarter 2021 (xlsx)
October 21, 2021 at 03:54 am EDT
Income Statement
Income Statement Borregaard Group Q3 2021
1.7-30.9
1.1-30.9
1.1-31.12
Amounts in NOK million
2021
2020
2021
2020
2020
Operating revenues
1,429
1,260
4,359
3,990
5,328
Operating expenses
-1,038
-994
-3,250
-3,121
-4,196
EBITDA
391
266
1,109
869
1,132
Depreciation property, plant and equipment
-103
-112
-310
-333
-443
Amortisation intangible assets
-1
-1
-3
-3
-5
Other income and expenses
0
0
0
-96
-116
Operating profit
287
153
796
437
568
Financial items, net
-18
-20
-55
-60
-72
Profit before taxes
269
133
741
377
496
Income tax expence
-64
-34
-174
-109
-117
Profit for the period
205
99
567
268
379
Profit attributable to non-controlling interests
-6
-13
-23
-47
-57
Profit attributable to owners of the parent
211
112
590
315
436
Earnings per share (NOK)
2.12
1.12
5.93
3.15
4.36
EBITDA margin
27.4 %
21.1 %
25.4 %
21.8 %
21.2 %
Balance Sheet
Interim condensed statement of financial position Borregaard Group
30/9/
30/6/
31/12/
Amounts in NOK million
2021
2021
2020
Assets:
Intangible assets
90
93
86
Property, plant and equipment
4,052
4,009
3,973
Right-of-use assets
358
369
381
Other assets
277
272
380
Investments in joint venture and associate company
147
39
38
Non-current assets
4,924
4,782
4,858
Inventories
799
769
887
Receivables
1,180
1,273
1,051
Cash and cash deposits
184
246
207
Current assets
2,163
2,288
2,145
Total assets
7,087
7,070
7,003
Equity and debt:
Group equity
4,023
3,875
3,668
Non-controlling interests
92
96
110
Equity
4,115
3,971
3,778
Provisions and other liabilities
305
321
291
Interest-bearing liabilities
1,351
1,346
1,381
Non-current liabilities
1,656
1,667
1,672
Interest-bearing liabilities
313
508
623
Other current liabilities
1,003
924
930
Current liabilities
1,316
1,432
1,553
Equity and liabilities
7,087
7,070
7,003
Equity ratio (%):
58.1 %
56.2 %
53.9 %
Cashflow
Interim condensed cash flow statement Borregaard Group Q3 2021
1.7-30.9
1.1-30.9
1.1-31.12
Amounts in NOK million
2021
2020
2021
2020
2020
Profit before taxes
269
133
741
377
496
Amortisation, depreciation and impairment charges
104
113
313
336
449
Change in net working capital, etc
8
-57
82
-221
-21
Dividend (share of profit) from JV
0
0
0
63
51
Taxes paid
-3
-36
-61
-85
-89
Cash flow from operating activities
378
153
1,075
470
886
Investments property, plant and equipment and intangible assets *
-219
-99
-439
-312
-503
Other capital transactions
2
-3
5
2
14
Cash flow from Investing activities
-217
-102
-434
-310
-489
Dividends
0
0
-249
-229
-229
Proceeds from exercise of options/shares to employees
9
5
55
34
35
Buy-back of shares
-23
-11
-111
-61
-62
Gain/(loss) on hedges for net investments in subsidiaries
-6
-2
11
-49
10
Net paid to/from shareholders
-20
-8
-294
-305
-246
Proceeds from interest-bearing liabilities
0
400
300
1,350
1,550
Repayment of interest-bearing liabilities
-212
-516
-668
-1,446
-1,703
Change in interest-bearing receivables/other liabilities
1
4
-5
30
18
Change in net interest-bearing liablities
-211
-112
-373
-66
-135
Cash flow from financing activities
-231
-120
-667
-371
-381
Change in cash and cash equivalents
-70
-69
-26
-211
16
Cash and cash equivalents at beginning of period
143
-59
96
81
81
Change in cash and cash equivalents
-70
-69
-26
-211
16
Currency effects cash and cash equivalents
3
1
6
3
-1
Cash and cash equivalents at the end of the period
76
-127
76
-127
96
* Investment by category:
Replacement investments
56
52
208
191
344
Expansion investments
163
47
231
121
159
Segment
Quarterly segment information Borregaard Group
Operating revenues
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.1
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.1-30.9
Amounts in NOK million
2017
2018
2019
2019
2019
2019
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
Borregaard
4,618
4,785
1,250
1,340
1,239
1,234
5,063
1,372
1,358
1,260
1,338
5,328
1,419
1,511
1,429
4,359
BioSolutions
2,594
2,775
755
781
720
726
2,982
797
819
733
733
3,082
812
885
838
2,535
BioMaterials
1,672
1,661
394
472
430
416
1,712
454
417
403
458
1,732
523
482
468
1,473
Fine Chemicals
370
374
110
96
96
104
406
128
131
131
153
543
90
155
132
377
Eliminations
-18
-25
-9
-9
-7
-12
-37
-7
-9
-7
-6
-29
-6
-11
-9
-26
EBITDA
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.1
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.1-30.9
Amounts in NOK million
2017
2018
2019
2019
2019
2019
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
Borregaard
1 055
903
255
283
286
183
1 007
242
361
266
263
1,132
302
416
391
1,109
BioSolutions
545
499
168
192
156
131
647
170
193
132
137
632
205
272
251
728
BioMaterials
414
312
45
64
94
31
234
46
101
91
80
318
64
102
91
257
Fine Chemicals
96
92
42
27
36
21
126
26
67
43
46
182
33
42
49
124
Depreciations and write downs
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.1
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.1-30.9
Amounts in NOK million
2017
2018
2019
2019
2019
2019
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
Borregaard
-306
-323
-98
-104
-106
-110
-418
-109
-112
-112
-110
-443
-106
-101
-103
-310
BioSolutions
-94
-113
-41
-44
-48
-50
-183
-51
-51
-53
-51
-206
-48
-45
-47
-140
BioMaterials
-192
-189
-49
-53
-50
-51
-203
-50
-52
-51
-50
-203
-50
-47
-47
-144
Fine Chemicals
-20
-21
-8
-7
-8
-9
-32
-8
-9
-8
-9
-34
-8
-9
-9
-26
Amortisation
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.1
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.1-30.9
Amounts in NOK million
2017
2018
2019
2019
2019
2019
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
Borregaard
-4
-4
-1
-1
-1
-1
-4
-1
-1
-1
-2
-5
-1
-1
-1
-3
BioSolutions
-4
-4
-1
-1
-1
-1
-4
-1
-1
-1
-2
-5
-1
-1
-1
-3
BioMaterials
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Fine Chemicals
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other income and expenses
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.1
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.1-30.9
Amounts in NOK million
2017
2018
2019
2019
2019
2019
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
Borregaard
-9
0
0
-16
0
-11
-27
0
-96
0
-20
-116
0
0
0
0
BioSolutions
-9
0
0
-16
0
0
-16
0
-90
0
-7
-97
0
0
0
0
BioMaterials
0
0
0
0
0
-11
-11
0
-6
0
-12
-18
0
0
0
0
Fine Chemicals
0
0
0
0
0
0
0
0
0
0
-1
-1
0
0
0
0
Operating profit (EBIT)
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.1
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.1-30.9
Amounts in NOK million
2017
2018
2019
2019
2019
2019
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
Borregaard
736
576
156
162
179
61
558
132
152
153
131
568
195
314
287
796
BioSolutions
438
382
126
131
107
80
444
118
51
78
77
324
156
226
203
585
BioMaterials
222
123
-4
11
44
-31
20
-4
43
40
18
97
14
55
44
113
Fine Chemicals
76
71
34
20
28
12
94
18
58
35
36
147
25
33
40
98
Hedging effects & currency exposure
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.1
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.1-30.9
Amounts in NOK million
2017
2018
2019
2019
2019
2019
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
Borregaard - EBITDA hedging gains & losses
-72
-11
-8
-13
-23
-32
-76
-62
-84
-51
-44
-241
-15
-4
-16
-35
BioSolutions
-22
3
-4
-6
-9
-14
-33
-26
-38
-21
-18
-103
-5
-1
-6
-12
BioMaterials
-36
-3
-3
-7
-11
-16
-37
-30
-39
-25
-22
-116
-8
-3
-8
-19
Fine Chemicals
-14
-11
-1
0
-3
-2
-6
-6
-7
-5
-4
-22
-2
0
-2
-4
Borregaard - USD EBITDA currency exposure (approx)
207
194
203
177
Borregaard - EUR EBITDA currency exposure (approx)
84
84
98
112
Sales revenues
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.1
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.1-30.9
Amounts in NOK million
2017
2018
2019
2019
2019
2019
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
Borregaard
4 522
4 705
1 222
1 311
1 214
1 204
4 951
1,347
1,337
1,229
1,314
5,227
1,394
1,491
1,406
4,291
BioSolutions
2 524
2 708
728
753
697
695
2 873
775
800
706
714
2,995
793
865
819
2,477
BioMaterials
1 634
1 630
385
465
422
407
1 679
445
407
395
448
1,695
513
472
457
1,442
Fine Chemicals
365
369
109
94
95
102
400
127
130
128
153
538
88
154
131
373
Eliminations
-1
-2
0
-1
0
0
-1
0
0
0
-1
-1
0
0
-1
-1
BioSolutions
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.1
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.1-30.9
2017
2018
2019
2019
2019
2019
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
Average gross sales price NOK per mtds
5 618
5 654
6 385
5 999
5 865
6 455
6 166
6,885
7,431
6,701
6,756
6,951
7,838
7,709
7,761
7,767
Volume (`000 mtds)
450
468
115
125
119
111
470
115
106
99
96
416
90
100
92
282
Specialities volume (`000 mtds)
83
86
86
88
Contruction volume (`000 mtds)
210
212
209
178
Industrial volume (`000 mtds)
157
170
175
150
BioMaterials
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.1
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.1-30.9
2017
2018
2019
2019
2019
2019
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
Average gross sales price NOK per mt
10 589
10 337
10 724
10 561
10 982
10 417
10 665
11 382
12 579
11 780
11 128
11 678
10 641
10 754
10 972
10 780
Volume (`000 mt)
150.7
150.1
34.5
42.4
37.6
38.6
153.1
40.0
33.9
34.2
40.3
148.4
47.5
42.4
40.2
130.1
High specialised as % of total cellulose product sales volum
72%
62%
73%
77%
Attachments
Original document
Permalink
Disclaimer
Borregaard ASA published this content on 21 October 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 21 October 2021 07:53:07 UTC .
Transcript : Borregaard ASA, Q1 2024 Earnings Call, Apr 24, 2024
Apr. 24
Borregaard to Issue NOK300 Million Commercial Paper
Apr. 17
MT
Nordic Stocks Declined Friday; Bravida Holding Took Biggest Hit
Apr. 05
DJ
Borregaard ASA Reports Earnings Results for the Full Year Ended December 31, 2023
Jan. 31
CI
Tranche Update on Borregaard ASA (OB:BRG)'s Equity Buyback Plan announced on November 28, 2023.
Jan. 31
CI
Borregaard ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Jan. 31
CI
Transcript : Borregaard ASA, Q4 2023 Earnings Call, Jan 31, 2024
Jan. 31
Borregaard ASA Proposes Cash Dividend for 2023, Payable on 22 April 2024
Jan. 31
CI
Kaffe Bueno ApS announced that it expects to receive ?6.2 million in funding from Borregaard ASA, European Innovation Council Fund and other investors
Dec. 21
CI
Nordic Stocks Moved Upward Monday; Schibsted Led Increases
Dec. 11
DJ
Lignovations announced that it has received ?2.2 million in funding from Borregaard ASA, Valnon Holding GmbH and other investors
Dec. 03
CI
Borregaard ASA (OB:BRG) commences an Equity Buyback Plan for 10% of its issued share capital, under the authorization approved from April 18, 2023.
Nov. 28
CI
Norwegian Biochemicals Group Borregaard Plans Share Buyback
Nov. 17
MT
Borregaard ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
23-10-24
CI
Transcript : Borregaard ASA, Q3 2023 Earnings Call, Oct 24, 2023
23-10-24
Borregaard Inks New Power Purchase Deal with Å Energi
23-10-18
MT
Borregaard ASA and A Energi Enter into New Long-Term Power Purchase Agreement for the Period 2024 to 2033
23-10-18
CI
Nordic Shares Closed Up Thursday; Truecaller Series B Topped Leaders
23-09-07
DJ
Transcript : Borregaard ASA, Q2 2023 Earnings Call, Jul 18, 2023
23-07-18
Borregaard ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-07-17
CI
Borregaard ASA Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-03
CI
Transcript : Borregaard ASA, Q1 2023 Earnings Call, May 03, 2023
23-05-03
Tranche Update on Borregaard ASA (OB:BRG)'s Equity Buyback Plan announced on April 7, 2022.
23-05-02
CI
Borregaard to Issue NOK300 Million Commercial Paper
23-04-20
MT
Transcript : Borregaard ASA - Shareholder/Analyst Call
23-04-18
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Borregaard ASA is a Norway-based biorafinery. The Group provides sustainable products and solutions based on renewable raw materials. Its business model is closely linked to the integrated nature of its biorefinery in Norway, which utilises the three key components of wood cellulose fibres, lignin and sugars to produce a diversified portfolio of products. The Company operates through three business segments. BioSolutions develops, produces and sells biopolymers and biovanillin from lignin. BioMaterials develops, produces and sells speciality cellulose mainly for use as a raw material in the production of cellulose ethers, cellulose acetate and other speciality products. Fine Chemicals consists of second-generation bioethanol and intermediates mainly for contrast agents.
More about the company
Average target price
201.5
NOK
Spread / Average Target
+6.05%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1